T cell responses to SARS-CoV-2
A large body of evidence generated in the last two and a half years addresses the roles of T
cells in SARS-CoV-2 infection and following vaccination. Infection or vaccination induces …
cells in SARS-CoV-2 infection and following vaccination. Infection or vaccination induces …
Impact of aging on immunity in the context of COVID-19, HIV, and tuberculosis
Knowledge of aging biology needs to be expanded due to the continuously growing number
of elderly people worldwide. Aging induces changes that affect all systems of the body. The …
of elderly people worldwide. Aging induces changes that affect all systems of the body. The …
Additive effects of booster mRNA vaccination and SARS-CoV-2 Omicron infection on T cell immunity across immunocompromised states
Suboptimal immunity to SARS-CoV-2 mRNA vaccination has frequently been observed in
individuals with various immunodeficiencies. Given the increased antibody evasion …
individuals with various immunodeficiencies. Given the increased antibody evasion …
Clinical characteristics of COVID-19 patients infected by the Omicron variant of SARS-CoV-2
J Zhang, N Chen, D Zhao, J Zhang, Z Hu… - Frontiers in medicine, 2022 - frontiersin.org
Background Currently, as the omicron variant of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) surges amid the coronavirus disease 2019 (COVID-19) …
coronavirus 2 (SARS-CoV-2) surges amid the coronavirus disease 2019 (COVID-19) …
Impact of COVID-19 on the liver and on the care of patients with chronic liver disease, hepatobiliary cancer, and liver transplantation: An updated EASL position paper
T Marjot, CS Eberhardt, T Boettler, LS Belli… - Journal of …, 2022 - Elsevier
The COVID-19 pandemic has presented a serious challenge to the hepatology community,
particularly healthcare professionals and patients. While the rapid development of safe and …
particularly healthcare professionals and patients. While the rapid development of safe and …
Memory T cells effectively recognize the SARS-CoV-2 hypermutated BA. 2.86 variant
T cells are critical in mediating the early control of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) breakthrough infection. However, it remains unknown whether …
coronavirus 2 (SARS-CoV-2) breakthrough infection. However, it remains unknown whether …
Response of COVID-19 vaccination in multiple sclerosis patients following disease-modifying therapies: A meta-analysis
X Wu, L Wang, L Shen, K Tang - EBioMedicine, 2022 - thelancet.com
Background COVID-19 vaccination is recommended for patients with multiple sclerosis
(pwMS), while disease-modifying therapies (DMTs) may influence the efficacy of SARS-CoV …
(pwMS), while disease-modifying therapies (DMTs) may influence the efficacy of SARS-CoV …
BNT162b2-boosted immune responses six months after heterologous or homologous ChAdOx1nCoV-19/BNT162b2 vaccination against COVID-19
GMN Behrens, J Barros-Martins, A Cossmann… - Nature …, 2022 - nature.com
Heterologous prime/boost vaccination with a vector-based approach (ChAdOx-1nCov-19,
ChAd) followed by an mRNA vaccine (eg BNT162b2, BNT) has been reported to be superior …
ChAd) followed by an mRNA vaccine (eg BNT162b2, BNT) has been reported to be superior …
T‐cell activation–induced marker assays in health and disease
C Poloni, C Schonhofer, S Ivison… - … and Cell Biology, 2023 - Wiley Online Library
Activation‐induced marker (AIM) assays have proven to be an accessible and rapid means
of antigen‐specific T‐cell detection. The method typically involves short‐term incubation of …
of antigen‐specific T‐cell detection. The method typically involves short‐term incubation of …
Evolution of long-term vaccine-induced and hybrid immunity in healthcare workers after different COVID-19 vaccine regimens
Background Both infection and vaccination, alone or in combination, generate antibody and
T cell responses against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …
T cell responses against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …